According to a new report, published by KBV research, The Global Ureteroscopy Market size is expected to reach $1.1 billion by 2028, rising at a market growth of 5.2% CAGR during the forecast period.
The Ambulatory Surgical Centers segment is showcasing a CAGR of 5.7% during (2022 - 2028). This is because Ureteroscopy is often conducted as an outpatient surgery. Ambulatory surgical centers are cutting-edge medical facilities that provide same-day surgical treatment, including diagnostic and preventative procedures. One benefit of getting treatment in an outpatient surgical facility is that it is considered safer and cleaner, which is especially important in the pandemic. The benefits associated with ASC are expected to surge the segment's expansion.
The Flexible segment acquired maximum revenue share in the Global Ureteroscopy Market by Product in 2021 thereby, achieving a market value of $752.5 Million by 2028. This is due to the benefits of flexible ureteroscopes, a rise in knowledge, and increased demand for early identification of chronic diseases such as kidney cancer and urinary tract infections, which call for extensive use of endoscopes for medical diagnostics. As a result, there is an upsurge in demand for flexible ureteroscopes as the prevalence of these disorders rises.
The Kidney Cancer segment has shown the growth rate of 6.5% during (2022 - 2028). Cancer that starts in the kidneys is known as kidney cancer. Two bean-shaped organs, each around the equivalent of a fist, make up the kidneys. One kidney is on either side of the spine and behind the abdominal organs. The ureters and renal pelvis are examined during a ureteroscopy using a narrow tube with a light & lens on the end (a ureteroscope). It is employed to search for any cancers or anomalous regions.
The North America market dominated the Global Ureteroscopy Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $415 Million by 2028. The Asia Pacific market is exhibiting a CAGR of 6% during (2022 - 2028). Additionally, The Europe market would showcase a CAGR of 4.9% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/ureteroscopy-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Boston Scientific Corporation, Olympus Corporation, Hoya Corporation, Steris PLC, Stryker Corporation, Advin Health Care, Karl Storz SE & Co. KG, Richard Wolf GmbH, Cliniva Healthcare, and OTU Medical Inc.
By End User
By Product
By Application
By Geography
Companies Profiled
Unique Offerings 
